Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
EPA CPDat observed this chemical in 1 composition records across product categories including Personal care.
Concern score
The concern value is driven by the published classifications and regulatory status below — not by a single signal.
Concern score 45/100 (moderate) · high confidence.
Prevalence of SODIUM STEARYL FUMARATE in our catalog (epa_cpdat).
Products
1
Brands
3
Typical roles
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
The published evidence profile currently shaping this ingredient record.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 1 composition records across product categories including Personal care. EPA CPDat classifies this chemical for functional uses including Filler, Leavening agent, Lubricating agent.
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 180 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 8 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 21 mg
US
FDA
Route: ORAL; Dosage form: GRANULE; Maximum daily exposure: 77 mg
US
FDA
Route: ORAL; Dosage form: GRANULE, FOR SOLUTION; Potency: 18.2 mg/120ml
US
FDA
Route: ORAL; Dosage form: LOZENGE; Maximum daily exposure: 125 mg
US
FDA
Route: ORAL; Dosage form: PELLET; Maximum daily exposure: 43 mg
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Potency: 3.74 mg/5ml
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 153 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 28 mg
US
FDA
Route: ORAL; Dosage form: TABLET, COATED; Potency: 1.18 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 216 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 42 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 98 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FOR SUSPENSION; Maximum daily exposure: 435 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 153 mg
US
FDA
Route: SUBLINGUAL; Dosage form: TABLET; Maximum daily exposure: 29 mg
US
FDA
openFDA substance registry classifies this ingredient as chemical.